Literature DB >> 6403964

Effect of naloxone and amphetamine on acquisition and memory consolidation of active avoidance responses in rats.

S Fulginiti, L M Cancela.   

Abstract

Pretraining IP injection of naloxone (0.3 mg/kg) or amphetamine (2 mg/kg) enhanced performance during acquisition, but did not improve retention of active avoidance responses in rats. Naloxone (0.1 or 3 mg/kg) had no effect on acquisition or on retention. The combination of naloxone (0.3 mg/kg) plus amphetamine (2 mg/kg) did not produce the facilitation observed when each of the two drugs was administered alone. Pretreatment with the higher dose of naloxone (3 mg/kg) blocked the facilitative effect of amphetamine on acquisition. Post-training administration of naloxone (0.3 mg/kg) or amphetamine (2 mg/kg) improved retention. Naloxone (0.1 or 3 mg/kg) had no effect. When naloxone and amphetamine were combined, at respective doses of 0.3 mg/kg and 2 mg/kg, the improvement did not occur, i.e., the higher dose of naloxone prevented the facilitative effect of amphetamine. In addition, an ineffective dose of amphetamine (0.5 mg/kg), given either pre- or post-training together with the lower dose of naloxone (0.1 mg/kg), produced a significant enhancement of acquisition or consolidation, respectively. The results are consistent with the possibility that naloxone might exert its facilitative action on acquisition and memory consolidation through the release of catecholaminergic systems from inhibitory influences of opioids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403964     DOI: 10.1007/BF00433015

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Effect of naloxone and morphine on various forms of memory in the rat: possible role of engogenous opiate mechanisms in memory consolidation.

Authors:  I Izquierdo
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

2.  Mecamylamine blockade of nicotine enhanced noradrenaline turnover in rat brain.

Authors:  W W Morgan; K A Pfeil
Journal:  Life Sci       Date:  1979-01-29       Impact factor: 5.037

3.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

4.  Norepinephrine: release from brain by d-amphetamine in vivo.

Authors:  L A Carr; K E Moore
Journal:  Science       Date:  1969-04-18       Impact factor: 47.728

5.  Naloxone enhancement of memory.

Authors:  R B Messing; R A Jensen; J L Martinez; V R Spiehler; B J Vasquez; B Soumireu-Mourat; K C Liang; J L McGaugh
Journal:  Behav Neural Biol       Date:  1979-11

6.  The effect of pre- and post-trial amphetamine injections on avoidance responses of rats.

Authors:  A M Evangelista; I Izquierdo
Journal:  Psychopharmacologia       Date:  1971

7.  Enkephalins interfere with acquisition of an active avoidance response.

Authors:  H Rigter; T J Hannan; R B Messing; J L Martinez; B J Vasquez; R A Jensen; J Veliquette; J L McGaugh
Journal:  Life Sci       Date:  1980-02-04       Impact factor: 5.037

8.  Facilitative effects of amphetamine on avoidance conditioning in relation to age and problem difficulty.

Authors:  B A Doty; L A Doty
Journal:  Psychopharmacologia       Date:  1966

9.  Enkephalin: a potential modulator of noradrenaline release in rat brain.

Authors:  H D Taube; E Borowski; T Endo; K Starke
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

10.  Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in rats.

Authors:  A J Kastin; E L Scollan; M G King; A V Schally; D H Coy
Journal:  Pharmacol Biochem Behav       Date:  1976-12       Impact factor: 3.533

View more
  10 in total

Review 1.  An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers.

Authors:  G L Wenk
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Cocaine enhances retention of avoidance conditioning in rats.

Authors:  P H Janak; G Keppel; J L Martinez
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone.

Authors:  D K Rush
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

5.  Skill-memory consolidation in the striatum: critical for late but not early long-term memory and stabilized by cocaine.

Authors:  Ingo Willuhn; Heinz Steiner
Journal:  Behav Brain Res       Date:  2008-07-18       Impact factor: 3.332

6.  Naloxone blockade of amphetamine place preference conditioning.

Authors:  K A Trujillo; J D Belluzzi; L Stein
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: dissociable serotoninergic involvement in avoidance learning, pain and motor function.

Authors:  S O Ogren; C Johansson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.

Authors:  F Camacho; C P Smith; H M Vargas; J T Winslow
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

9.  Amphetamine increases errors during episodic memory retrieval.

Authors:  Michael Edward Ballard; David A Gallo; Harriet de Wit
Journal:  J Clin Psychopharmacol       Date:  2014-02       Impact factor: 3.153

10.  Quaternary naloxone enhances acquisition of a discriminated Y-maze escape and a one-way active avoidance task in mice.

Authors:  J L Martinez; J S de Graaf
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.